论文部分内容阅读
目的:探讨复方丹参与654-2注射液在糖尿病性周围神经病变中的临床疗效。方法:选择符合诊断标准的糖尿病性周围神经病变患者,随机分为治疗组和对照组,对照组常规给予降糖、降脂,应用维生素B1、B12等以营养周围神经,治疗组以复方丹参和654-2联用。结果:治疗组总有效率为95.24%,对照组总有效率为38.10%,有显著性差异(P<0.01)。结论:复方丹参与654-2注射液治疗糖尿病复方丹参与654-2注射液效果明显,不良反应极少,值得临床推广。
Objective: To investigate the clinical efficacy of compound Salvia miltiorrhiza and 654-2 injection in diabetic peripheral neuropathy. Methods: Patients with diabetic peripheral neuropathy who met the diagnostic criteria were randomly divided into treatment group and control group. The control group was routinely given hypoglycemic and lipid-lowering drugs, and vitamin B1 and B12 were given to peripheral nerves. The treatment group was given Salvia miltiorrhiza and 654-2 together. Results: The total effective rate was 95.24% in the treatment group and 38.10% in the control group, with significant difference (P <0.01). Conclusion: Salvia miltiorrhiza and 654-2 injection are effective in treating diabetic patients with Salvia miltiorrhiza and 654-2 injection, with very few adverse reactions, which is worthy of clinical promotion.